Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-14028 in Rosacea
NCT02052999Phase 2Completed
- Sponsor
- Amorepacific Corporation
- Start
- Feb 2013
- Primary completion
- Jun 2013
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of asivatrep in rosacea, sponsored by Amorepacific Corporation. Started Feb 2013; status: completed.
02
Drugs
asivatrep
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT02052999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02052999.